# US 2026/0125413 A1 · Universal solid supports and phosphoramidite building blocks for oligonucleotide synthesis

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0125413 A1
- Document ID: US20260125413A1
- Status: Published application
- Kind: A1
- Application number: 19/106,597
- Filed: 2023-08-28
- Published: 2026-05-07
- Earliest claimed: 2022-08-26
- Assignees: AM Chemicals LLC
- Applicants: Am Chemicals LLC
- Inventors: Andrei Pavel Guzaev; Khirud Gogoi; Suzie Sheng; Harri Oskari Loennberg; Mikhail A. Guzaev
- Web page: https://patentgrep.com/patent/US20260125413A1

## CPC

- C07H 21/00: Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07D 451/04: with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
- C07D 451/06: Oxygen atoms
- C07D 451/10: acylated by aliphatic or araliphatic carboxylic acids, e.g. atropine, scopolamine
- C07D 451/12: acylated by aromatic or heteroaromatic carboxylic acids, e.g. cocaine
- C07F 9/6561: containing systems of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring or ring system, with or without other non-condensed hetero rings
- C07H 1/02: Phosphorylation
- C07B 2200/11: Compounds covalently bound to a solid support
- Y02P 20/55: Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
- C07H: SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS (derivatives of aldonic or saccharic acids C07C, C07D; aldonic acids, saccharic acids C07C59/105, C07C59/285; cyanohydrins C07C255/16; glycals C07D; compounds of unknown constitution C07G; polysaccharides, derivatives thereof C08B; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; sugar industry C13)
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- C07F: ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM (metal-containing porphyrins C07D487/22)
- C07B: GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR (preparation of carboxylic acid esters by telomerisation C07C67/47; telomerisation C08F)
- Y02P: CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS

## Abstract

Disclosed herein are chemical preparation of oligonucleotides, chemical entities useful in such preparation, processes for such preparation, and methods of use relating to the chemical preparation of oligonucleotides. Further disclosed herein are novel universal solid supports and phosphoramidite building blocks for oligonucleotide synthesis on solid phase that effect the removal of 3′-phosphate moieties during the course of oligonucleotide deprotection.

## Claims

### Claim 1

A compound of Formula I
wherein:
R1 and R2 either form an orthoester function —C(CH3)(OCH3)— or one of R1 and R2 is hydrogen, a trityl protecting group or a derivative thereof, or a xanthenyl protecting group or a derivative thereof, and the other of R1 and R2 is an acetyl, a propionyl, a n-butyryl, a benzoyl, or L1, wherein:
L1 is a linking moiety —C(═O)—Z—(C═O)-A1, wherein:
Z is selected from the group consisting of a covalent bond, a methylene group, —(CH2)2—, —(CH2)—O—(CH2)—, and —(CH2)—O—C6H4—O—(CH2)—;
A1 is a hydroxy group, a salt of a hydroxy group and an inorganic cation or a tertiary amine, a covalent bond to SP1, or —NH(CH2)n—OR7, wherein:
SP1 is an oxygen, amino, an aminoalkyl or a hydroxyalkyl covalently attached to a solid phase material comprising a controlled pore glass, a magnetic controlled pore glass, a silica-containing particle, a styrene-containing polymer or copolymer, a divinylbenzene-containing polymer or copolymer, a copolymer of styrene and divinylbenzene, a controlled pore glass grafted with a styrene-containing polymer, a controlled pore glass grafted with a copolymer of styrene and divinylbenzene, a copolymer of styrene and divinylbenzene grafted with polyethylene glycol, or a flat glass surface;
n is an integer from 2 to 10;
R7 is hydrogen or PA, wherein:
and wherein R8 is methyl or 2-cyanoethyl group and R14 is an alkyl, iso-alkyl, sec-alkyl, or tert-alkyl;
R3 is selected from the group consisting of methyl, ethyl, propyl, isopropyl, and benzyl;
R4 is selected from the group consisting of a lone electron pair, hydrogen, methyl, ethyl, propyl, isopropyl, and benzyl, wherein when R4 is other than a lone electron pair, N has a positive charge and forms a salt with a halide anion or with an intramolecular carboxylic functional group;
R5 and R6 are independently hydrogen or methyl;
Y is —(C═O)—, —CH(OR9)—, —CH(NR10R11)—, or —[C(OR12)(OR13)]—, wherein:
R9 is hydrogen, methyl, ethyl, benzyl, acetyl, propionyl, butyryl, isobutyryl, pivaloyl, benzoyl, t-butyldimethylsilyl, triisopropylsilyl, (t-butyl) diphenylsilyl, —(C═O)A1, L1, or PA wherein:
m is an integer ranging from 2 to 10;
R10 is L1, —(C═O)-A1, or —(C═O)-W1-(CH2)p—W2, wherein:
W1 is —(CH2)—, —(NH)—, or —(NH)(C═O)—;
W2 is a hydroxy, amino, —O—PA, (C═O)-A1, or —[NH(C═O)]-A1; and
p is an integer from 2 to 10;
R11 is hydrogen, methyl, ethyl, or benzyl; and
R12 and R13 together form ketal bridges —(CH2)2— or —CH2 [C(CH3)2]—CH2—;
provided one and only one of R1, R2, and Y is or includes L1 or PA.

### Claim 2 (depends on 1)

The compound of claim 1 wherein one of R1 and R2 is hydrogen, tris-(4-methoxyphenyl)methyl, bis-(4-methoxyphenyl)phenylmethyl, 9-phenylxanthen-9-yl, or 9-(4-methoxyphenyl)xanthen-9-yl, and the other of R1 and R2 is L1 wherein:
A1 is a hydroxy group, a salt of a hydroxy group and an inorganic cation or a tertiary amine, or a covalent bond to SP1; and
(i) Y is —CH(OR9)—, wherein R9 is methyl, ethyl, benzyl, acetyl, propionyl, butyryl, isobutyryl, pivaloyl, benzoyl, t-butyldimethylsilyl, triisopropylsilyl, or phenyldimethylsilyl; or
(ii) Y is —[C(OR12)(OR13)]—.

### Claim 3 (depends on 1)

The compound of claim 1 wherein one of R1 and R2 is hydrogen tris-(4-methoxyphenyl)methyl, or bis-(4-methoxyphenyl)phenylmethyl, and the other of R1 and R2 is acetyl, propionyl, n-butyryl, or benzoyl.

### Claim 4 (depends on 3)

The compound of claim 3 wherein
(i) Y is —CH(OR9)—, wherein R9 is L1, and wherein A1 is a hydroxy group optionally forming a salt with an inorganic cation or a tertiary amine, or optionally forming a covalent bond to SP1; or
(ii) Y is —CH(NR10R11), wherein R11 is hydrogen, methyl, ethyl, or benzyl, and
(a) R10 is L1 wherein A1 is a hydroxy group, a salt of a hydroxy group and an inorganic cation or a tertiary amine, or a covalent bond to SP1; or
(b) R10 is —(C═O)-W1-(CH2)p—W2, wherein:
W2 is an amino, —(C═O)-A1, or —[NH(C═O)]-A1 wherein A1 is a hydroxy group, a salt of a hydroxy group and an inorganic cation or a tertiary amine, or a covalent bond to SP1; and
p is an integer from 3 to 10.

### Claim 5 (depends on 1)

The compound of claim 1 wherein one of R1 and R2 is tris-(4-methoxyphenyl)methyl or bis-(4-methoxyphenyl)phenylmethyl and the other of R1 and R2 is L1 wherein:
(i) A1 is-NH(CH2)n—OR7; and
(ii) Y is —CH(OR9), wherein R9 is methyl, ethyl, benzyl, acetyl, propionyl, butyryl, isobutyryl, pivaloyl, benzoyl, t-butyldimethylsilyl, triisopropylsilyl, or phenyldimethylsilyl.

### Claim 6 (depends on 1)

The compound of claim 1 wherein one of R1 and R2 is tris-(4-methoxyphenyl)methyl or bis-(4-methoxyphenyl)phenylmethyl and the other of R1 and R2 is acetyl, propionyl, n-butyryl, or benzoyl and Y is —CH(OR9)—, wherein:
(i) R9 is PA, or
(ii) R9 is —(CH2)m—O-PA.

### Claim 7 (depends on 1)

The compound of claim 1 wherein one of R1 and R2 is tris-(4-methoxyphenyl)methyl or bis-(4-methoxyphenyl)phenylmethyl, the other of R1 and R2 is acetyl, propionyl, n-butyryl, or benzoyl, and Y is —CH(NR10R11), wherein R11 is hydrogen, methyl, ethyl, or benzyl, wherein:
R10 is —(C═O)-W1-(CH2)p—W2, and wherein:
W1 is —(CH2)—, —(NH)—, or —(NH)(C═O)—, and
W2 is hydroxy or O-PA.

### Claim 8 (depends on 1)

The compound of claim 1 wherein R1 and R2 form an orthoester function —C(CH3)(OCH3)—, and wherein
(i) Y is —CH(OR9)—; and
(ii) R9 is hydrogen, PA, or —(CH2)m—O-PA.

### Claim 9 (depends on 1)

The compound of claim 1, wherein the trityl protecting group or the derivative thereof or the xanthenyl protecting group or the derivative thereof is selected from the group consisting of 4-methoxytrityl, 4,4′-dimethoxytrityl, 4,4′,4″-trimethoxytrityl, 9-phenylxanthen-9-yl, and 9-(4-methoxyphenyl)xanthen-9-yl.

### Claim 10

A method for functionalizing a solid phase material with a first monomeric subunit, comprising the steps of:
(a) providing a solid phase material-bound compound of Formula I
wherein:
R1 and R2 either form an orthoester function —C(CH3)(OCH3)— or one of R1 and R2 is hydrogen, a trityl protecting group or a derivative thereof, or a xanthenyl protecting group or a derivative thereof and the other of R1 and R2 is an acetyl, a propionyl, a n-butyryl, a benzoyl, L1, wherein:
L1 is a linking moiety —C(═O)—Z—(C═O)-A1, wherein:
Z is selected from the group consisting of a covalent bond, a methylene group, —(CH2)2—, —(CH2)—O—(CH2)—, and —(CH2)—O—C6H4—O—(CH2)—;
A1 is a covalent bond to SP1 or —NH(CH2)n—OR7, wherein:
SP1 is an oxygen, amino, an aminoalkyl or a hydroxyalkyl covalently attached to a solid phase material comprising a controlled pore glass, a magnetic controlled pore glass, a silica-containing particle, a styrene-containing polymer or copolymer, a divinylbenzene-containing polymer or copolymer, a copolymer of styrene and divinylbenzene, a controlled pore glass grafted with a styrene-containing polymer, a controlled pore glass grafted with a copolymer of styrene and divinylbenzene, a copolymer of styrene and divinylbenzene grafted with polyethylene glycol, and a flat glass surface;
n is an integer from 2 to 10;
R7 is PX, wherein:
and wherein R8 is methyl or 2-cyanoethyl group and X is oxygen or sulfur;
R3 is selected from the group consisting of methyl, ethyl, propyl, isopropyl, and benzyl;
R4 is selected from the group consisting of a lone electron pair, hydrogen, methyl, ethyl, propyl, isopropyl, and benzyl, wherein when R4 is other than a lone electron pair, N has a positive charge and forms a salt with a halide anion or with an intramolecular carboxylic functional group;
R5 and R6 are independently hydrogen or methyl;
Y is —(C═O)—, —CH(OR9)—, —CH(NR10R11), or —[C(OR12)(OR13)]—, wherein:
R9 is hydrogen, methyl, ethyl, benzyl, acetyl, propionyl, butyryl, isobutyryl, pivaloyl, benzoyl, t-butyldimethylsilyl, triisopropylsilyl, or (t-butyl) diphenylsilyl group, —(C═O)A1 L1, or PX, wherein:
m is an integer ranging from 2 to 10;
R10 is L1, —(C═O)-A1, or —(C═O)-W1 (CH2)p—W2, wherein:
W1 is —(CH2)—, —(NH)—, or —(NH)—(C═O)—;
W2 is —O—PX, or —[NH(C═O)]-A1; and
p is an integer ranging from 2 to 10;
R11 is hydrogen, methyl, ethyl, or benzyl; and
R12 and R13 together form ketal bridges —(CH2)2— or —CH2—[C(CH3)2]—CH2—;
provided one and only one of R1, R2, and Y is or includes L1 or PX;
(b) selectively removing one of the protecting groups of Formula I to form a reactive hydroxyl group;
(c) providing a first monomeric subunit comprising an activated phosphorus group and a protected hydroxy group, and reacting the activated phosphorus group of the first monomeric subunit with the reactive hydroxyl group of the compound of Formula I to form a monomer-functionalized solid support comprising a phosphite group;
(d) treating said monomer-functionalized solid support with a capping agent and/or treating said monomer-functionalized solid support with an oxidizing solution or a sulfurizing agent to convert the phosphite triester group to a phosphotriester or phosphothioate triester, thereby forming an oxidized or sulfurized functionalized solid support;
(e) optionally repeating steps (b), (c), and (d) one or more times for the oxidized or sulfurized functionalized solid support to form an oligomeric-functionalized solid support, wherein the monomeric subunit is the same or different each time steps (b), (c), and (d) are repeated.

### Claim 11 (depends on 10)

The method of claim 10, further comprising deprotecting the oligomeric-functionalized solid support of step (e) and cleaving the oligomeric-functionalized solid support to form an oligomeric compound separate from the solid phase material, wherein the cleaving forms a terminal hydroxy group on the oligomeric compound at the site of cleavage.

### Claim 12 (depends on 10)

The method of claim 10, wherein one of R1 or R2 is L1.

### Claim 13 (depends on 10)

The method of claim 10, wherein R7 is PX.

### Claim 14 (depends on 10)

The method of claim 10, wherein the activated phosphorus group comprises a phosphoramidite, an H-phosphonate, or a phosphate triester.

### Claim 15 (depends on 11)

The method of claim 11, wherein the oligomeric compound is an oligonucleotide, optionally comprising unnatural sugar-modified nucleotide residues, unnatural base-modified nucleotide residues, or non-nucleotide monomeric units.
